Authors: Giermasz, A Nowis, D Jalili, A Basak, G Marczak, M Makowski, M Czajka, A Mlynarczuk, I Hoser, G Stok, T Lewandowski, S Jakobisiak, M

Citation: A. Giermasz et al., Antitumor activity of tributyrin in murine melanoma model, CANCER LETT, 164(2), 2001, pp. 143-148

Authors: Mlynarczuk, I Hoser, G Grzela, T Stoklosa, T Wojcik, C Malejczyk, J Jakobisiak, M

Citation: I. Mlynarczuk et al., Augmented pro-apoptotic effects of TRAIL and proteasome inhibitor in humanpromonocytic leukemic U937 cells, ANTICANC R, 21(2A), 2001, pp. 1237-1240

Authors: Feleszko, W Mlynarczuk, I Nowis, D

Citation: W. Feleszko et al., In vitro antitumor activity of cerivastatin, a novel and potent HMG-CoA reductase inhibitor, FEBS LETTER, 503(2-3), 2001, pp. 219-220

Authors: Wojcik, C Bury, M Stoklosa, T Giermasz, A Feleszko, W Mlynarczuk, I Pleban, E Basak, G Omura, S Jakobisiak, M

Citation: C. Wojcik et al., Lovastatin and simvastatin are modulators of the proteasome, INT J BIO C, 32(9), 2000, pp. 957-965

Authors: Feleszko, W Mlynarczuk, I Balkowiec-Iskra, EZ Czajka, A Switaj, T Stoklosa, T Giermasz, A Jakobisiak, M

Citation: W. Feleszko et al., Lovastatin potentiates antitumor activity and attenuates cardiotoxicity ofdoxorubicin in three tumor models in mice, CLIN CANC R, 6(5), 2000, pp. 2044-2052

Authors: Wojcik, C Mlynarczuk, I Hoser, G Kawiak, J Stoklosa, T Golab, J Wilk, S

Citation: C. Wojcik et al., A combination of retinoic acid and proteasome inhibitors for the treatmentof leukemias is potentially dangerous, BLOOD, 94(5), 1999, pp. 1827-1828